Bayer And Simulations Plus Collaborate to Advance ADMET Predictor for Improving Data Integrity in Drug Discovery

 Bayer And Simulations Plus Collaborate to Advance ADMET Predictor for Improving Data Integrity in Drug Discovery

Bayer And Simulations Plus Collaborate to Advance ADMET Predictor for Improving Data Integrity in Drug Discovery

Shots:

  • Simulation Plus to develop improved structure and tautomer handling capabilities in its ADMET Predictor machine learning software which will sustenance data integrity across Bayer’s platforms
  • Under the collaboration, Bayer will utilize ML software to maintain data integrity and to prevent information loss across its platforms while Simulations Plus retains rights to license new functionality to all its clients
  •  The collaboration will improve efficiencies in drug discovery as compound libraries are virtually screened utilizing ADMET models

Click here to­ read full press release/ article | Ref: Simulations Plus | Image: Simulations Plus

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post